10x Genomics, Inc. TXG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -67.08M | -75.13M | -22.66M | -43.54M | -76.32M |
| Total Depreciation and Amortization | 41.23M | 42.02M | 40.17M | 38.23M | 36.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.66M | 108.61M | 108.36M | 116.42M | 123.16M |
| Change in Net Operating Assets | 12.89M | 51.58M | 1.95M | 24.94M | 4.99M |
| Cash from Operations | 99.70M | 127.09M | 127.82M | 136.05M | 88.53M |
| Capital Expenditure | -5.93M | -5.65M | -5.64M | -5.94M | -6.87M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -6.75M | -15.37M | -9.27M | -9.27M | -8.62M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.33M | 1.37M | 2.05M | 1.77M | -47.74M |
| Cash from Investing | -11.35M | -19.65M | -12.86M | -13.44M | -63.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.06M | 6.15M | 6.65M | 6.80M | 9.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.69M | -8.69M | -8.69M | -- | -- |
| Cash from Financing | 5.37M | -2.54M | -2.04M | 6.80M | 9.08M |
| Foreign Exchange rate Adjustments | -239.00K | -91.00K | 297.00K | 484.00K | 172.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.48M | 104.80M | 113.22M | 129.90M | 34.55M |